Status:
COMPLETED
Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese(MEGA Study)
Lead Sponsor:
Mitsukoshi Health and Welfare Foundation
Collaborating Sponsors:
Daiichi Sankyo Co., Ltd.
Ministry of Health, Labour and Welfare, Japan
Conditions:
Hyperlipidemia
Eligibility:
All Genders
40-70 years
Phase:
PHASE4
Brief Summary
To evaluate the primary preventive effect of low-dose pravastatin against coronary heart disease (CHD) in Japanese hypercholesterolemic patients.
Detailed Description
MEGA Study is the first prospective, randomized, controlled trial conducted in Japan to evaluate the primary preventive effect of pravastatin against CHD in daily clinical practice. Because the dose o...
Eligibility Criteria
Inclusion
- TC:220～270mg/dl
- Male: 40-70 years old/ female: postmenopausal-70 years old
- \<40kg in weight
Exclusion
- FH
- History of CHD(angina, MI, post-PTCA/CABG, etc.)
- History of CVA(stroke, TIA, etc.)
- Underlying malignant tumor
Key Trial Info
Start Date :
February 1 1994
Trial Type :
INTERVENTIONAL
End Date :
March 1 2004
Estimated Enrollment :
8000 Patients enrolled
Trial Details
Trial ID
NCT00211705
Start Date
February 1 1994
End Date
March 1 2004
Last Update
December 4 2006
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.